Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Nutrition ; 29(1): 138-42, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23116775

ABSTRACT

OBJECTIVE: Iron supplementation is commonly recommended for infants; however, there are some reports that it causes oxidative damage. The aim of this study was to investigate the potential effects of iron supplementation at 4 mo of age, for a period of 2 mo, on lipid peroxidation and free radical scavenging enzymes. METHODS: Twenty-seven healthy 4-mo-old infants chosen randomly and given iron supplementation (ferrous sulfate, 10 mg of elemental iron per day) constituted the study group and 26 healthy 4-mo-old infants who were chosen randomly and not given iron supplementation constituted the control group. Weight, height, head circumference, complete blood cell count, serum ferritin level and intraerythrocytic zinc, iron, copper, malondialdehyde, catalase, superoxide dismutase, and glutathione peroxidase levels were measured in the two groups at 4 and 6 mo of life. RESULTS: Compared with controls at 6 mo of age, no significant differences were observed for intraerythrocytic zinc (0.5 ± 0.1 versus 0.6 ± 0.2 µg/mL, P > 0.05), copper (0.2 ± 0.1 versus 0.2 ± 0.2 µg/mL, P > 0.05), iron (130.8 ± 10.9 versus 127.4 ± 11.1 µg/mL, P > 0.05), malondialdehyde (21.4 ± 3.5 versus 22.4 ± 2.3 nmol/g of hemoglobin, P > 0.05), catalase (135.4 ± 23.9 versus 135.1 ± 23.3 MU/g of hemoglobin, P > 0.05), superoxide dismutase (1736.4 ± 141.1 versus 1701.3 ± 103.9 U/g of hemoglobin, P > 0.05), and glutathione peroxidase (8.9 ± 1.6 versus 8.4 ± 1.6 U/g of hemoglobin, P > 0.05) levels. CONCLUSION: Our study indicates that the supplemental use of elemental iron 10 mg/d for a period of 2 mo in healthy iron-replete infants did not cause lipid peroxidation or an impairment of antioxidant status.


Subject(s)
Antioxidants/metabolism , Iron, Dietary/adverse effects , Lipid Peroxidation/drug effects , Catalase/blood , Copper/blood , Dietary Supplements/adverse effects , Erythrocytes/drug effects , Erythrocytes/metabolism , Female , Ferritins/blood , Ferrous Compounds/administration & dosage , Ferrous Compounds/adverse effects , Free Radical Scavengers/metabolism , Glutathione Peroxidase/blood , Humans , Infant , Iron/blood , Iron Deficiencies , Iron, Dietary/administration & dosage , Male , Superoxide Dismutase/blood , Zinc/blood
3.
Clin Appl Thromb Hemost ; 16(6): 637-42, 2010 Dec.
Article in English | MEDLINE | ID: mdl-19633022

ABSTRACT

This study was performed to investigate the platelet aggregation alterations in platelet-rich plasma (PRP) samples of children with Helicobacter pylori (H pylori) infection. Platelet aggregation induced by adenosine diphosphate (ADP), collagen, ristocetin, or epinephrine was studied with photometric aggregometry in 30 patients before and after eradication therapy and in a control group including 15 children. The pretreatment mean maximum aggregation values and slope were significantly lower (P < .0001) in the study group at 10 µmol/L concentrations of ADP (ADP-like defect). The maximum aggregation values and slope revealed no significant differences (P > 0.05) between the study group after therapy and the control group. We concluded that H pylori infection may cause dysfunction of platelets in children and can be reversed by H pylori eradication therapy. Further studies should be carried out to determine the mechanisms of platelet dysfunction in children with H pylori infection.


Subject(s)
Helicobacter Infections/blood , Helicobacter pylori/physiology , Platelet Aggregation/physiology , Adenosine Diphosphate/pharmacology , Adolescent , Blood Platelets/drug effects , Blood Platelets/physiology , Case-Control Studies , Child , Collagen/pharmacology , Epinephrine/pharmacology , Female , Helicobacter Infections/drug therapy , Humans , Male , Platelet Aggregation/drug effects , Platelet-Rich Plasma/drug effects , Platelet-Rich Plasma/physiology , Ristocetin/pharmacology
4.
Pediatr Neurol ; 41(6): 461-3, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19931172

ABSTRACT

Vincristine is a vinca alkaloid used in combination with other agents in the treatment of solid tumors, lymphoma, and leukemia, as well as for idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia. A dose-limiting complication of vinca alkaloids is neurotoxicity. Vincristine is the oldest and also the most neurotoxic agent in this group. Described here is the case of a 4-year-old girl with unilateral palpebral ptosis. She has been diagnosed with precursor B-cell acute lymphoblastic leukemia. Ptosis was noted on the 45th day of therapy, and the last vincristine was administered on the 28th day of protocol 1. Vincristine-induced unilateral palpebral ptosis is a novel finding. Experience with this case suggests conservative treatment, with periodic examination, especially if ptosis is mild.


Subject(s)
Antineoplastic Agents, Phytogenic/adverse effects , Blepharoptosis/chemically induced , Functional Laterality , Vincristine/adverse effects , Antineoplastic Agents, Phytogenic/therapeutic use , Blepharoptosis/pathology , Child, Preschool , Female , Humans , Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Time Factors , Treatment Outcome , Vincristine/therapeutic use
5.
J Pediatr Endocrinol Metab ; 22(12): 1179-83, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20333880

ABSTRACT

Osteopetrorickets is a rare autosomal recessive disorder of osteoclast function characterized by abnormally dense bone and failure of resorption of calcified cartilage. Rickets is a paradoxical complication of osteopetrosis, resulting from the inability of the osteoclasts to maintain a normal calcium-phosphorus balance in the extracellular fluid. We report a patient with an unusual case of infantile osteopetro-rickets who was admitted with anterior fontanel bulging and was treated with haploidentical bone marrow transplantation.


Subject(s)
Bone Density Conservation Agents/administration & dosage , Bone Marrow Transplantation , Calcitriol/administration & dosage , Osteopetrosis/drug therapy , Rickets/drug therapy , Combined Modality Therapy , Dose-Response Relationship, Drug , Female , Humans , Infant , Osteopetrosis/diagnostic imaging , Radiography , Rickets/diagnostic imaging
6.
Turk J Pediatr ; 50(5): 438-42, 2008.
Article in English | MEDLINE | ID: mdl-19102047

ABSTRACT

Captopril and enalapril are the most commonly used angiotensin converting enzyme inhibitors in several cardiac diseases in children. On the other hand, the intrinsic renin-angiotensin system in the bone marrow might affect the growth of hematopoietic colonies and cellular production, proliferation and differentiation in physiological and pathological states. Starting with the hypothesis that inhibition of the renin-angiotensin system may have some effects on the hematopoietic system, including morphological changes within the granulocytes, we thus aimed to investigate prospectively whether the use of angiotensin converting enzyme inhibitors has any effect on the morphology, and especially segmentation, of neutrophils in peripheral blood. A total of 40 children with various heart diseases receiving either of two angiotensin converting enzyme inhibitors (captopril or enalapril) aged between 2 to 16 years were enrolled, and 40 healthy age- and sex-matched children were enrolled as controls. Complete blood count, peripheral blood smear, liver and renal function tests, and measurement of serum alkaline phosphatase, ferritin, vitamin B12 and folate levels were performed in all cases. Peripheral blood smears were viewed by two pediatric hematologists in a blinded manner. Neutrophil hypersegmentation was described as presence of five or more neutrophils with five well-separated lobes or at least one neutrophil with six or more lobes among 100 segmented neutrophils. The number of patients with neutrophil hypersegmentation in the study group was significantly higher than in the control group, and the mean lobe count in the study group was significantly higher than in the control group. Neutrophil hypersegmentation, as detected in patients using angiotensin converting enzyme inhibitors in the present study, has not been reported previously. Further studies aiming to explain the pathophysiological mechanism(s) underlying neutrophil hypersegmentation in patients receiving angiotensin converting enzyme inhibitors are needed.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Heart Diseases/blood , Neutrophils/pathology , Adolescent , Child , Child, Preschool , Female , Follow-Up Studies , Heart Diseases/drug therapy , Humans , Leukocyte Count , Male , Neutrophils/drug effects , Retrospective Studies
7.
J Pediatr Hematol Oncol ; 28(3): 170-2, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16679943

ABSTRACT

Immune thrombocytopenic purpura in childhood is characterized by a typical history of acute development of purpura and bruising in an otherwise healthy child. In children it usually follows a viral infection (eg, mumps, rubella) or immunization. We report for the first time a child with acute lymphoblastic leukemia who developed immune thrombocytopenic purpura due to mumps during the maintenance phase of acute lymphoblastic leukemia treatment.


Subject(s)
Mumps/complications , Neoplasm Recurrence, Local/complications , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Purpura, Thrombocytopenic, Idiopathic/etiology , Child , Humans , Male , Mumps/physiopathology , Neoplasm Recurrence, Local/physiopathology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/physiopathology , Purpura, Thrombocytopenic, Idiopathic/physiopathology , Thrombocytopenia/etiology , Thrombocytopenia/physiopathology
8.
Turk J Pediatr ; 48(4): 334-9, 2006.
Article in English | MEDLINE | ID: mdl-17290568

ABSTRACT

There has been little or no evidence of brainstem auditory evoked potentials (BAEPs) among infants with iron deficiency (ID) that is not severe enough to cause anemia. To our knowledge, the effect of ID on auditory functions and/or potentials has not been investigated previously, though it seems reasonable that it should be associated with BAEP measures intermediate between those observed in iron deficiency anemia (IDA) and in iron sufficiency, considering the role of iron in myelin formation and maintenance. We therefore aimed in this study to investigate the effect of ID on BAEPs by comparing three groups of infants with ID, IDA and iron sufficiency (control) both before and after iron treatment (in iron-deficient groups). Three groups of infants (IDA, n = 25; ID, n = 24; Control, n = 44) were compared on the basis of hematological laboratory parameters and BAEP measurements both at entry into and after (12 weeks treatment with oral iron in IDA and ID groups) the study. BAEP measurements recorded at 85 dB both at entry into and after the study were not significantly different among the groups, although a sufficient response to iron treatment was achieved in iron-deficient groups (Group I and Group II). The only positive finding determined in our study was a slight decrease in latencies obtained at the end of the study when compared to the pre-study values in all three groups of the study in accordance with the expected age-dependent developmental changes. Although no negative electrophysiological effect of ID on brainstem auditory functions was found in the present study, further longer term (late childhood or adult) studies are necessary to elucidate the relationships among anemia (maybe other than IDA), ID and auditory functions, and clinical implications of hearing loss (if any) should be questioned.


Subject(s)
Anemia, Iron-Deficiency/physiopathology , Evoked Potentials, Auditory, Brain Stem , Iron Deficiencies , Administration, Oral , Age Factors , Analysis of Variance , Anemia, Iron-Deficiency/complications , Anemia, Iron-Deficiency/diagnosis , Child, Preschool , Female , Ferrous Compounds/administration & dosage , Ferrous Compounds/therapeutic use , Follow-Up Studies , Hearing/physiology , Hearing Loss/etiology , Humans , Infant , Male , Time Factors
9.
Nephrology (Carlton) ; 10(5): 427-9, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16221088

ABSTRACT

BACKGROUND: beta-thalassemia minor is a common heterozygous haemoglobinopathy that is characterized by both microcytosis and hypochromia. It requires no treatment. It has been postulated that low-grade haemolysis, tubular iron deposition and toxins derived from erythrocytes might cause renal tubular damage in adult patients with beta-thalassemia minor. Our aim was to investigate the renal tubular functions in children with beta-thalassemia minor and to determine its possible harmful effects. METHODS: The study was conducted on 32 children (14 female and 18 male) at the age of 5.8 +/- 3.1 years (range 2-14 years) with beta-thalassemia minor. The patients were classified as anaemic (haemoglobin (Hb) 11 g/dL) (Group 2, n = 18). A control group was formed with 18 healthy children whose ages and sexes match those in other groups (Group 3, n = 18). Fractional excretion of sodium (FE(Na), %), fractional excretion of magnesium (FE(Mg), %), fractional excretion of uric acid (FE(UA), %) and tubular phosphorus reabsorption (TPR,%) were calculated with standard formulas. Urinary calcium excretion (mg/kg per 24 h), zinc (Zn) (microg/dL), glucosuria (mg/dL), beta-2 microglobulin (mg/dL) and N-acetyl-beta-D-glycosaminidase (NAG, U/mmol creatinine) levels were measured through biochemical methods. RESULTS: There was no statistically significant difference among the three groups in terms of the results of FE(Na) (%), FE(Mg) (%), FE(UA) (%), TPR (%), calciuria (mg/kg per 24 h), NAG, urine Zn, proteinuria, glucosuria or urine beta- 2 microglobulin levels (P > 0.05). CONCLUSION: On the contrary of children with beta-thalassemia major, renal tubular dysfunction has not been determined in children with beta-thalassemia minor in the present study.


Subject(s)
Kidney Diseases/etiology , Kidney Tubules/physiology , beta-Thalassemia/complications , Acetylglucosaminidase/urine , Adolescent , Calcium/urine , Child , Child, Preschool , Female , Glycosuria, Renal/etiology , Glycosuria, Renal/urine , Humans , Kidney Diseases/urine , Male , Proteinuria/etiology , Proteinuria/urine , Zinc/urine , beta 2-Microglobulin/urine , beta-Thalassemia/urine
10.
Pediatr Hematol Oncol ; 22(3): 219-22, 2005.
Article in English | MEDLINE | ID: mdl-16020105

ABSTRACT

This article describes an unusual association of familial high plasma factor VIII level and necrotizing fasciitis in a 4-year-old girl with primary varicella infection.


Subject(s)
Chickenpox/complications , Factor VIII/analysis , Family , Fasciitis, Necrotizing/complications , Chickenpox/diagnosis , Child, Preschool , Fasciitis, Necrotizing/diagnosis , Fasciitis, Necrotizing/therapy , Female , Humans
11.
Biol Trace Elem Res ; 105(1-3): 197-203, 2005.
Article in English | MEDLINE | ID: mdl-16034164

ABSTRACT

The inhalation of a wide range of organic solvents has become popular among young adults. Toluene is one of the most commonly used solvents in industry; it is easily available and convenient to use. Many toxicologic effects on biological systems secondary to deliberate inhalation of toluene have been reported, but investigations on adverse effects associated with bone morbidity is limited. The purpose of this study is to determine bone mineralization and investigate the adverse effects of toluene on bone. The bone mineral density and content of the femoral neck of mice exposed to toluene at 300 ppm for 8 wk were measured by dual X-ray absorptiometry and found significantly reduced compared to the control group. Chronic exposure to toluene was found to affect bone metabolism, and toluene-induced changes could contribute to bone resorption and inhibition of bone formation. Toluene seems to be the responsible component for the demineralizating effects of commonly abused substances, and medical doctors must promote their education about the health hazards in those who abuse solvents especially in areas where inhalant abuse is endemic.


Subject(s)
Administration, Inhalation , Bone and Bones/drug effects , Toluene/toxicity , Absorptiometry, Photon , Animals , Bone Density , Inhalation Exposure , Male , Mice , Mice, Inbred BALB C , Solvents/toxicity , Substance-Related Disorders
12.
Blood Coagul Fibrinolysis ; 16(2): 145-7, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15741803

ABSTRACT

Recombinant activated factor VII (rFVIIa) is a major alternative for management of hemophiliac patients with inhibitors. Additionally, it has been used off-label for the treatment of massive life-threatening hemorrhage associated with various bleeding situations. Herein, we describe a 16-month-old boy with acute megakaryoblastic leukemia and severe intractable gastrointestinal bleeding controlled by rFVIIa. rFVIIa should be considered as a novel treatment alternative in severe bleeding conditions including leukemias that may have hemostatic defects and platelet dysfunction.


Subject(s)
Factor VII/administration & dosage , Gastrointestinal Hemorrhage/drug therapy , Leukemia, Megakaryoblastic, Acute , Recombinant Proteins/administration & dosage , Factor VIIa , Gastrointestinal Hemorrhage/etiology , Humans , Infant , Leukemia, Megakaryoblastic, Acute/complications , Leukemia, Megakaryoblastic, Acute/drug therapy , Male
13.
Pediatr Hematol Oncol ; 21(7): 593-6, 2004.
Article in English | MEDLINE | ID: mdl-15626015

ABSTRACT

Helicobacter pylori gastritis has been associated with autoimmune disease, including immune thrombocytopenic purpura (ITP). The most recent reports also have supported this association in adults. ITP in children differs from that in adults in terms of clinical picture and mechanisms of thrombocytopenia. The authors report a case of a 12-year-old boy with chronic ITP, in whom they detected H. pylori infection and observed a complete platelet recovery after the eradication of H. pylori.


Subject(s)
Helicobacter Infections , Helicobacter Infections/drug therapy , Platelet Count , Purpura, Thrombocytopenic, Idiopathic/blood , Amoxicillin/therapeutic use , Child , Clarithromycin/therapeutic use , Drug Therapy, Combination/therapeutic use , Helicobacter Infections/complications , Humans , Male , Purpura, Thrombocytopenic, Idiopathic/etiology
SELECTION OF CITATIONS
SEARCH DETAIL